カテゴリ： MarketLine, アメリカ, 企業調査

Estee Lauder Companies Inc：企業の戦略・SWOT・財務情報

◆英語タイトル：Estee Lauder Companies Inc - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C5537
◆発行会社（調査会社）：MarketLine
◆発行日：2018年10月
◆ページ数：48
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：消費財
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Estee Lauder Companies Inc – Strategy, SWOT and Corporate Finance Report
Summary

Estee Lauder Companies Inc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Estee Lauder Companies Inc. (Estee Lauder) is a manufacturer and marketer of personal care products. Its product portfolio includes skin care, makeup, fragrance, and hair care products. The company markets own and designer brands such as Estee Lauder, Aramis, Clinique, Origins, M.A.C, La Mer, Bobbi Brown Aveda, Tommy Hilfiger, Donna Karan, Michael Kors, Ermenegildo Zegna, and Tom Ford. The company sells its products through several channels such as department stores, specialty retailers, upscale perfumeries and pharmacies, salons, spas and authorised freestanding stores, stores on cruise ships, in-flight, and duty-free shops, worldwide. The company has presence in Asia, Europe, the Middle East, Africa and the Americas. Estee Lauder is headquartered in New York, the US.

Scope

- Detailed information on Estee Lauder Companies Inc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Estee Lauder Companies Inc in the form of a SWOT analysis
- An in-depth view of the business model of Estee Lauder Companies Inc including a breakdown and examination of key business segments
- Intelligence on Estee Lauder Companies Inc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Estee Lauder Companies Inc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Estee Lauder Companies Inc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Estee Lauder Companies Inc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Estee Lauder Companies Inc’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
The Estee Lauder Companies Inc: Company Overview 9
The Estee Lauder Companies Inc: Overview and Key Facts 9
The Estee Lauder Companies Inc: Overview 9
The Estee Lauder Companies Inc: Key Facts 9
The Estee Lauder Companies Inc: Key Employees 10
The Estee Lauder Companies Inc: Key Employee Biographies 12
The Estee Lauder Companies Inc: Major Products and Services 14
The Estee Lauder Companies Inc: Company History 16
The Estee Lauder Companies Inc: Management Statement 22
The Estee Lauder Companies Inc: Key Competitors 23
The Estee Lauder Companies Inc: Company Analysis 24
The Estee Lauder Companies Inc: Business Description 24
The Estee Lauder Companies Inc: SWOT Analysis 26
The Estee Lauder Companies Inc: SWOT Overview 26
The Estee Lauder Companies Inc: Strengths 26
The Estee Lauder Companies Inc: Weaknesses 27
The Estee Lauder Companies Inc: Opportunities 28
The Estee Lauder Companies Inc: Threats 28
The Estee Lauder Companies Inc: Corporate Financial Deals Activity 30
The Estee Lauder Companies Inc: Financial Deals Overview 30
The Estee Lauder Companies Inc: Targets and Partners 32
The Estee Lauder Companies Inc: Top Deals 2014 – 2018YTD* 33
The Estee Lauder Companies Inc: Advisors 34
The Estee Lauder Companies Inc: Top Legal Advisors 34
The Estee Lauder Companies Inc: Top Financial Advisors 34
The Estee Lauder Companies Inc: Mergers and Acquisitions 36
The Estee Lauder Companies Inc: Corporate Venturing 37
The Estee Lauder Companies Inc: Capital Raising 38
The Estee Lauder Companies Inc: Recent Developments 39
The Estee Lauder Companies Inc: News and Events Summary 39
The Estee Lauder Companies Inc: Business Expansion 41
The Estee Lauder Companies Inc: Contracts 42
The Estee Lauder Companies Inc: Corporate Governance 42
The Estee Lauder Companies Inc: Financial Deals 43
The Estee Lauder Companies Inc: Financial Performance 44
The Estee Lauder Companies Inc: Strategy and Operations 44
Appendix 46
Contact Us 46
Methodology 46
About MarketLine 47

List of Tables
Table 1: The Estee Lauder Companies Inc: Key Facts
Table 2: The Estee Lauder Companies Inc: Key Employees
Table 3: The Estee Lauder Companies Inc: Company History
Table 4: The Estee Lauder Companies Inc: Key Competitors
Table 5: The Estee Lauder Companies Inc: Deal Activity by Deal Type - Volume (TTM*)
Table 6: The Estee Lauder Companies Inc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: The Estee Lauder Companies Inc: M&A Average Deal Size - Value (US$m)
Table 8: The Estee Lauder Companies Inc: Targets and Partners
Table 9: The Estee Lauder Companies Inc: Top Deals 2014 - 2018YTD*
Table 10: The Estee Lauder Companies Inc: Legal Advisor Ranking by Value (US$m)
Table 11: The Estee Lauder Companies Inc: Financial Advisor Ranking by Value (US$m)
Table 12: The Estee Lauder Companies Inc: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: The Estee Lauder Companies Inc: M&A Activity by Geography (2014 - YTD*2018)
Table 14: The Estee Lauder Companies Inc: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 15: The Estee Lauder Companies Inc: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 16: The Estee Lauder Companies Inc: Capital Raising by Deal Type (2014 - YTD*2018)
Table 17: The Estee Lauder Companies Inc: News and Events Summary
Table 18: The Estee Lauder Companies Inc: Business Expansion
Table 19: The Estee Lauder Companies Inc: Contracts
Table 20: The Estee Lauder Companies Inc: Corporate Governance
Table 21: The Estee Lauder Companies Inc: Financial Deals
Table 22: The Estee Lauder Companies Inc: Financial Performance
Table 23: The Estee Lauder Companies Inc: Strategy and Operations

List of Figures
Figure 1: The Estee Lauder Companies Inc: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: The Estee Lauder Companies Inc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: The Estee Lauder Companies Inc: M&A Average Deal Size - Value (US$m)
Figure 4: The Estee Lauder Companies Inc: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: The Estee Lauder Companies Inc: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: The Estee Lauder Companies Inc: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 7: The Estee Lauder Companies Inc: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 8: The Estee Lauder Companies Inc: Capital Raising by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Estee Lauder Companies Inc：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Team Health Holdings Inc-製薬・医療分野：企業M&A・提携分析
    Summary Team Health Holdings Inc (TeamHealth) is a healthcare organization that offers patient care services. The organization’s practice areas include emergency medicine, anesthesiology, hospital medicine, hospital medicine subspecialties, ambulatory care, post-acute care and behavioral health serv …
  • Lloyd’s Register Group Ltd：企業の戦略的SWOT分析
    Lloyd's Register Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • BioVentrix Inc：医療機器：M&Aディール及び事業提携情報
    Summary BioVentrix Inc (BioVentrix) is a medical device company that develops congestive heart failure treatment solutions. The company offers revivent myocardial anchoring systems, a device that restores the size, volume and resulting function of the left ventricle for improving cardiac function in …
  • The Bangchak Petroleum PCL (BCP)：企業の財務・戦略的SWOT分析
    The Bangchak Petroleum PCL (BCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • RainDance Technologies Inc-製薬・医療分野：企業M&A・提携分析
    Summary RainDance Technologies Inc (RDT) is a developer of genomic tools for non-invasive liquid biopsy applications. The company’s products include RainDrop Plus, a digital PCR system that provides picoliter droplets for multiplex detection of HIV and DNA. It also offers RainDrop Plus digital PCR s …
  • Cogentix Medical Inc (CGNT)：企業の財務・戦略的SWOT分析
    Summary Cogentix Medical Inc (Cogentix Medical), formerly Vision-Sciences Inc, is a medical device company that designs, develops, manufactures and markets fiberoptic and video endoscopy products. The company’s major products include PrimeSight endoscopy systems, Urgent PC neuromodulation system and …
  • Glu Mobile Inc (GLUU)：企業の財務・戦略的SWOT分析
    Glu Mobile Inc (GLUU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Primary Health Care Ltd (PRY)：企業の財務・戦略的SWOT分析
    Primary Health Care Ltd (PRY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Swiss Life Holding Ltd：企業の戦略・SWOT・財務情報
    Swiss Life Holding Ltd - Strategy, SWOT and Corporate Finance Report Summary Swiss Life Holding Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Washington University in St Louis：製薬・医療：M&Aディール及び事業提携情報
    Summary Washington University in St Louis (WUSTL), a subsidiary of University of Washington is an educational university which provides education and research services. The university provides various courses of bachelor’s, master’s, and doctoral degrees in a wide range of traditional and interdisci …
  • Eurazeo SA：企業のM&A・事業提携・投資動向
    Eurazeo SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Eurazeo SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Strabag SE：企業の戦略・SWOT・財務情報
    Strabag SE - Strategy, SWOT and Corporate Finance Report Summary Strabag SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Akebia Therapeutics Inc (AKBA)：製薬・医療：M&Aディール及び事業提携情報
    Summary Akebia Therapeutics Inc (Akebia Therapeutics) is a biopharmaceutical company focused on the development and commercialization of novel therapeutics based on hypoxia inducible factor for patients with kidney disease and other metabolic disorders. Its lead product candidate vadadustat is a HIF …
  • Bioceros BV-製薬・医療分野：企業M&A・提携分析
    Summary Bioceros BV (Bioceros) is a biopharmaceutical company which provides services related to preclinical development of monoclonal antibodies. The company offers GMP-ready protein producing cell lines. The company provides services which include monoclonal antibody generation, cell line and proc …
  • Takeda Pharmaceutical Company Limited：企業のM&A・事業提携・投資動向
    Takeda Pharmaceutical Company Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Takeda Pharmaceutical Company Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed report …
  • KKR & Co. Inc：企業の戦略・SWOT・財務分析
    KKR & Co. Inc - Strategy, SWOT and Corporate Finance Report Summary KKR & Co. Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Ziehm Imaging GmbH-医療機器分野：企業M&A・提携分析
    Summary Ziehm Imaging GmbH (Ziehm Imaging) is a medical device company that specializes in the development, production and global marketing of mobile X-ray based imaging solutions. The company's product portfolio includes ziehm vision RFD 3D, ziehm vision RFD hybrid edition, ziehm vision RFD, ziehm …
  • Sumol+Compal SA：企業の戦略・SWOT・財務情報
    Sumol+Compal SA - Strategy, SWOT and Corporate Finance Report Summary Sumol+Compal SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Zavante Therapeutics Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Zavante Therapeutics Inc (Zavante), formerly SG Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops novel therapies for the treatment of infectious diseases such as due to multi-drug resistant (MDR) bacteria. The company offers drugs for the treatment of diseases …
  • ING Life Insurance Company Korea, Ltd.：企業の戦略・SWOT・財務情報
    ING Life Insurance Company Korea, Ltd. - Strategy, SWOT and Corporate Finance Report Summary ING Life Insurance Company Korea, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆